EXPERT OPINION ON THERAPEUTIC TARGETS

Journal Title
EXPERT OPINION ON THERAPEUTIC TARGETS

EXPERT OPIN THER TAR

ISSN / eISSN
1472-8222 / 1744-7631
Aims and Scope
The journal evaluates molecules, signalling pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and early preclinical studies. Articles should not include clinical information including specific drugs and clinical trials.

The Editors welcome:

Reviews covering novel disease targets at the molecular level and information on early preclinical studies and their implications for future drug development.
Articles should not include clinical information including specific drugs and clinical trials.
Original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs.
The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.
Subject Area

PHARMACOLOGY & PHARMACY

CiteScore
8.90 View Trend
CiteScore Ranking
Category Quartile Rank
Pharmacology, Toxicology and Pharmaceutics - Pharmacology Q1 #52/313
Pharmacology, Toxicology and Pharmaceutics - Drug Discovery Q1 #29/157
Pharmacology, Toxicology and Pharmaceutics - Clinical Biochemistry Q1 #23/117
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine Q1 #43/178
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
PHARMACOLOGY & PHARMACY Q1
H-index
78
Country/Area of Publication
ENGLAND
Publisher
Taylor and Francis Ltd.
Publication Frequency
Monthly
Year Publication Started
2001
Annual Article Volume
93
Open Access
NO
Contact
INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation